Citi initiates Madrigal Pharmaceuticals coverage with Buy rating
Tweet Send to a Friend
(Updated - September 23, 2026 5:04 AM EDT)
Citi analyst Eric Joseph initiated coverage on Madrigal Pharmaceuticals (NASDAQ: MDGL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Eric Joseph initiated coverage on Madrigal Pharmaceuticals (NASDAQ: MDGL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
